Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 10/2012

Inhalt (23 Artikel)

Original Paper

CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α)

Chuanyang Sun, Hui Song, Hua Zhang, Chuansheng Hou, Tianhang Zhai, Lv Huang, Liang Zhang

Original Paper

Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer

Eun Kyoung Jeon, Hye-Sung Won, Yoon-Ho Ko, In Seok Lee, Tae Ho Hong, Young Kyoung You, Myung Ah Lee

Original Paper

Prognostic value of tumor progression-related gene expression in colorectal cancer patients

Miriam E. Uhlmann, Milka Georgieva, Martin Sill, Ulrich Linnemann, Martin R. Berger

Original Paper

miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes

Yong-Kui Zhang, Wang-Yu Zhu, Jian-Ying He, Dong-Dong Chen, Yan-Yan Huang, Han-Bo Le, Xiao-Guang Liu

Original Paper

Fusion between tumor cells enhances melanoma metastatic potential

Ruifang Mi, Chunxiao Pan, Xiaocui Bian, Liqiang Song, Wenjia Tian, Fang Cao, Juan Yin, Haiyong Peng, Jianhui Ma

Original Paper

Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study

Murat Zor, Ibrahim Yildirim, Seref Basal, Halil Yaman, Mustafa Ozturk, Cem Hasan Irkilata, Serdar Goktas, Murat Dayanc

Original Paper

Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival

Matt Williams, Zi Wei Liu, David Woolf, Sarah Hargreaves, Vasiliki Michalarea, Rebecca Menashy, Ishminder Kooner, Elena Wilson

Original Paper

XPD Asp312Asn polymorphism is a risk factor for prostate cancer

Shao-Guang Liao, Lu Liu, Ying Wang, Ying-Yi Zhang, Ya-Jie Wang

Original Paper

Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma

Marta Hegyi, Ágnes Gulácsi, Edit Cságoly, Katalin Csordás, Olivér T. Eipel, Dániel J. Erdélyi, Judit Müller, Karolina Nemes, Orsolya Lautner-Csorba, Gábor T. Kovács

Original Paper

N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer

Xiu-Hong Lv, Jia-Wei Chen, Gang Zhao, Zhen-Zhong Feng, Dao-Hua Yang, Wei-Wei Sun, Jin-Shuang Fan, Guang-Hui Zhu

Original Paper

Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma

Ying Jin, Xiu-Yu Cai, Yan-Xia Shi, Xi-Ya Xia, Yu-Chen Cai, Ye Cao, Wei-Dong Zhang, Wei-Han Hu, Wen-Qi Jiang

Original Paper

Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production

Guangying Du, Liang Ye, Guoying Zhang, Qiuju Dong, Kun Liu, Jingwei Tian

Original Paper

Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?

Linlin Liu, Nian Liu, Baogang Liu, Yanming Yang, Qi Zhang, Weijing Zhang, Pengyue Yu, Yonglong Jin, Jia Guo, Songlei Guan, Shilong Sun, Lining Miao, Jun Wei

Original Paper

Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB

Moon Hee Yang, Kyu Taek Lee, Sera Yang, Jong Kyoon Lee, Kwang Hyuck Lee, Il Hwan Moon, Jong Chul Rhee

Original Paper

HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents

Emmanuelle Tavernier, Pascale Flandrin-Gresta, Françoise Solly, Lauren Rigollet, Jérôme Cornillon, Karine Augeul-Meunier, Jean-Louis Stephan, Aurélie Montmartin, Annie Viallet, Denis Guyotat, Lydia Campos

Original Paper

Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer

Yaming Du, Leizhi Shi, Tianyi Wang, Zhiliang Liu, Zhongbin Wang

Original Paper

Expression and biological role of δ-catenin in human ovarian cancer

Yuanyuan Fang, Zhengtao Li, Xiuxia Wang, Shulan Zhang

Erratum

Erratum to: Expression and biological role of δ-catenin in human ovarian cancer

Yuanyuan Fang, Zhengtao Li, Xiuxia Wang, Shulan Zhang

Original Paper

RETRACTED ARTICLE: Radioembolization using Yttrium-90 microspheres in 58 patients with liver metastases from breast cancer

Changming Shen, Xueling Yang, Aisidi Tecle, Cheng Tian, Qiang Li

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.